Nonetheless, oral treatment such as levodopa has shown their efficacy on specific subgroups of HSP (SPG11 mimicking dopa-responsive dystonia and variant phenotype linked to GCH1 mutations)66,67. The gene discussed is GCH1; the disease is Dystonia.